ARENDAL, NO / SHERBROOKE, QC. 22 November 2023 – Tekna (OSE: TEKNA), a world-leading provider of advanced materials solutions to industry, is pleased to announce another significant order valued at CAD 1.5 million for titanium powder for medical applications.
The contract is for Tekna’s main-size titanium alloy powder exclusively used for medical applications and is scheduled for delivery within the first three quarters of 2024. This represents a notable 60% increase in orders from this customer compared to the previous year and forms part of a three-year distribution agreement. The customer is a leading distributor of titanium powder, holding a significant position in the medical and dental industry across Europe and worldwide. This partnership not only broadens Tekna’s presence but also enhances its influence in a global market.
“This substantial order is a testament to Tekna’s growing influence and reputation in the advanced materials industry, particularly in the medical sector, which has grown to become one of the most advanced and prominent users of additive manufacturing on a global scale. Partnering with a key player in the European market not only strengthens our position but also highlights the trust and reliability associated with our products. We are proud to play a pivotal role in advancing medical technologies through our specialized titanium powders,” said Luc Dionne, CEO of Tekna.”
This contract underscores Tekna’s commitment to excellence and innovation in the field of advanced materials and their dedication to meeting the increasing demands of the medical sector. With this new agreement, Tekna continues to solidify its position as a key supplier of specialized materials on a global scale. Tekna’s quality management system is ISO13485:2016 certified for medical applications.
Arina Van Oost, Investor Relations | VP Corporate Strategic Development & Innovation, Tekna Holding ASA,
+1 438 885 6330, +33670115190, [email protected]
